期刊文献+

急性冠状动脉综合征患者血中嗜铬粒蛋白A、脑尿钠肽、去甲肾上腺素水平变化临床观察 被引量:2

原文传递
导出
摘要 目的探讨急性冠状动脉综合征患者血中嗜铬粒蛋白A(CgA)、脑尿钠肽(BNP)与去甲肾上腺素(NE)水平变化情况。方法选择2012年6月1日至2013年6月1日急性冠状动脉综合征患者98例为观察组。选择同期门诊健康体检者98例为对照组,比较两组血中CgA、BNP与NE水平变化。结果与对照组患者相比,观察组患者外周血液中CgA、BNP和NE水平明显较高,差异有统计学意义,(P〈0.05);患者外周血液中的CgA、BNP与NE水平随着急性冠状动脉综合征的加重而不断升高。结论急性冠状动脉综合征患者外周血液中的CgA、BNP与NE水平与正常人相比明显升高,上述三项指标可作为诊断急性冠状动脉综合征的重要指标。
作者 刘振玉
出处 《中国实用医刊》 2014年第7期118-119,共2页 Chinese Journal of Practical Medicine
  • 相关文献

二级参考文献18

  • 1孙同文,张彦周,李莉,杨海波,曹剑英,党瑜华,黄振文.脑钠肽对急性冠状动脉综合征近期预后的评价[J].临床心血管病杂志,2005,21(3):176-178. 被引量:3
  • 2陈忠,马根山,冯毅,罗丹,严金川,沈成兴,戴启明,丁建东.不同类型冠心病病人血浆脑钠肽检测及其意义[J].中国急救医学,2005,25(4):253-254. 被引量:14
  • 3赵明中,胡大一,陈学英,朱天刚,刘如辉.高敏C反应蛋白水平变化预测无ST段抬高急性冠状动脉综合征患者的临床预后[J].中华心血管病杂志,2005,33(4):378-378. 被引量:18
  • 4刘江峰,孙同文,唐璐,茹祥伟.监测脑钠肽水平评价美托洛尔治疗慢性心力衰竭的疗效[J].新乡医学院学报,2005,22(5):483-484. 被引量:5
  • 5[1]叶任高.内科学.人民卫生出版社,2005:983-985.
  • 6[2]Subodh V,Shu HL,Mitesh V,et al.Endothelin antagonism and interleukin-6 inhibition attenuate the pmatherogenic effects of C-reactive Protein.Circulation,2002,105:1890-1896.
  • 7[4]Jousilahti P,Salomaa V,Rasi V,et al.The association of creactive protein,serum amyloid A and fibrinogen witll prevalent coronary heart disease-baseline findings of the PAIS project.Athemscleresis,2001,156(2):451-456.
  • 8[5]Johnson BD,Kip KE,Marroquin OC,et al.Serum amyloid A as a predictor of coronary artery disease andcardiovascular outcome in women:the National Heart,Lung,and Blood Institute-Sponsored Women S Ischemia Syndrome Evaluation (WISE).Circulation,2004,109:726-732.
  • 9[6]Asada J,Tsuji H,Lwasaka T,et al.Usefulness of plasma brain natriuretie peptide levels in predicting dobutamine-induced myocardial ischemio.Am J Cardiol,2004,93:702-704.
  • 10[7]Omland T,Persson A,Ng L,et al.N·terminal pro·B-type nalaiuretic peptide and long-term mortality in acute coronary syndromes.Circulation,2002,106:2913-2918.

共引文献9

同被引文献32

  • 1Hanada S, Takewa Y, Mizuno T, et al. Effect of the technique for assisting renal blood circulation on is- chemic kidney in acute cardiorenal syndrome[J]. J Artif Organs ,2012,15(2) .. 140-145.
  • 2Lassus JP, Harjola VP, Peuhkurinen K, et al. Cystatin C, NT-proBNP and inflammatory markers in acute heart failure insights into the cardiorenal syndrome [J]. Biomarkers,2011,16(4) :302-310.
  • 3Bosselmann H, Tonder N, Soletormos G, et al. Influ- ence of renal impairment on myocardial function in outpatients with systolic heart failure: an echocardio- graphic and cardiac biomarker study[J]. Int J Cardiol, 2014,177(3) : 942-948.
  • 4Hanna EB, Hanna Deschamps E. Acute heart failure.. acute cardiorenal syndrome and role of aggressive de- congestion[J]. Clin Cardiol, 2014,37 (12) : 773-778.
  • 5Palazzuoli A, Geyer A, Malandrino A, et al. Current therapeutic strategies in cardiorenal syndrome[J]. Minerva Cardioangiol, 2012,94 (14) : 375-383.
  • 6Taub PR, Borden KC, Fard A, et al. Role of bi-omar- kers in the diagnosis and prognosis of acute kidney injury in patients with cardiorenal syndrome[J]. Ex- pert Rev Cardiovasc Ther,2012,10(5) : 657-667.
  • 7Malbrain ML, Roberts DJ, Sugrue M, et al. The po- lycompartment syndrome., a concise state-of-the-art review [J]. Anaesthesiol Intensive Ther, 2014, 46 (5) :433-450.
  • 8Goussot S, Mousson C, Guenancia C: et al. N-Terminal Fragment of Pro B-type Natriuretic Peptide as a Marker of Contrast-Induced Nephropathy After Primary Percutaneous Coronary Intervention for ST- Segment Elevation Myocardial Infarction. Am J Cardiol, 2015, 116(6) :865-871.
  • 9Bosselmann H, Tonder N, S:16tormos G, et al. Influence of renal impairment on myocardial function in outpatients with systolic heart failure: An echocardiographic and cardiac biomarker study. Int J Cardio1,2014,177 ( 3 ) :942-948.
  • 10Lassus J P, Harjola V P, Pcuhkurinen K, et al. Cystatin CNT- proBNP and inflammatory markers in acute heart failure insights into the cardiorenal syndrome. Biomarkers,2011,16(4) :302-310.

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部